Asia Cell Therapeutics (Shanghai) Co., Ltd.
Asia Cell Therapeutics (Shanghai) Co., Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis | Axial Spondyloarthritis, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, spondylitis, vertebral column disorder | Not yet recruiting | Phase 1 | 2023-08-15 | NCT05962762 | |
| Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Not yet recruiting | Phase 1 | 2023-08-09 | NCT05983627 | |
| Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis | Decompensated Liver Cirrhosis | Not yet recruiting | Phase 1 / Phase 2 | 2023-07-17 | NCT05948982 |